Veterinarian graduated at Universidade de São Paulo (2003), with MBAs in Project Management (2010) and Business Strategic and Economic Management (2015) at Fundação Getúlio Vargas. Executive with 15 years of experience in the animal health industry, playing technical and marketing roles in local and multinational companies. From products/business development and regulatory affairs to marketing, strategy and revenue management. Specialist in innovation management in products, services and business models.

Wolfgang Haag

Managing Director – Brazil

Vetoquinol

Wolfgang Haag

Managing Director – Brazil

Vetoquinol

Fabio Paganini

Head, Latin America Region Animal Health

Boehringer Ingelheim

Fabio Paganini

Head, Latin America Region Animal Health

Boehringer Ingelheim

Fernanda Hoe

R&D Leader Brazil Ops, Global Cattle Product Development

Elanco

Veterinary Medicine degree from Unesp - Botucatu, Brazil

Master in Science from the University of Wisconsin, USA

MBA from FGV, Brazil.

More than 15 years of experience in the Animal Health Industry. Experience in technical, sales, marketing with focus on customer insights, product positioning and launching. Since 2016 leading the R&D team in Brazil.

Fernanda Hoe

R&D Leader Brazil Ops, Global Cattle Product Development

Elanco

Veterinary Medicine degree from Unesp - Botucatu, Brazil

Master in Science from the University of Wisconsin, USA

MBA from FGV, Brazil.

More than 15 years of experience in the Animal Health Industry. Experience in technical, sales, marketing with focus on customer insights, product positioning and launching. Since 2016 leading the R&D team in Brazil.

Osvaldo Ciasulli

Director-Editor

Revista feed&food

Osvaldo Ciasulli

Director-Editor

Revista feed&food

Luciano Aba

Editor

MOTIVAR

I have always been linked to journalism, and have worked for 15 years in the field of health and productivity for different animal species in Argentina.

I aim to highlight the work of veterinary professionals in the field and have tried to reflect in my articles the importance of good advice in everything that has to do with productivity.

The objective is to position the different media in which I work, as a generator of debates that favor the greatest growth of all the actors linked to Animal Health and Productivity.

Luiz Luccas

Luiz Luccas

Business Development

ALPHA HLD

Bernardo Arrospide

Co-Founder & CEO

4Vets

Bernardo Arrospide

Co-Founder & CEO

4Vets

Carolina Padovani

Scientific Affairs & Communication Manager

Royal Canin Brazil

Carolina Padovani has been the Scientific Affairs & Communication Manager at Royal Canin Brazil since January 2016. Her backgroud is in veterinary medicine and she has a master's degree in pet nutrition. She started her career at Royal Canin with a regulatory affairs implementation area in 2010. Since then she has developed some projects and get the opportunity to navigate in different areas such as R&D, MKT, Corporate Affairs, Public Affairs. In her current position, she manages the areas of technical knowledge and relationship with KOL and universities.

Carolina Padovani

Scientific Affairs & Communication Manager

Royal Canin Brazil

Carolina Padovani has been the Scientific Affairs & Communication Manager at Royal Canin Brazil since January 2016. Her backgroud is in veterinary medicine and she has a master's degree in pet nutrition. She started her career at Royal Canin with a regulatory affairs implementation area in 2010. Since then she has developed some projects and get the opportunity to navigate in different areas such as R&D, MKT, Corporate Affairs, Public Affairs. In her current position, she manages the areas of technical knowledge and relationship with KOL and universities.

Bruno Ducatti

Co-Founder

Vet Smart

Entrepreneur and co-creator of the company, and developer of Brazil's largest platform of online communication between companies and veterinarians. Participation in the design of new products. Acting with commercial negotiations and strategic partnerships. Expertise in mobile technology and communication and branding strategies.

Bruno Ducatti

Co-Founder

Vet Smart

Entrepreneur and co-creator of the company, and developer of Brazil's largest platform of online communication between companies and veterinarians. Participation in the design of new products. Acting with commercial negotiations and strategic partnerships. Expertise in mobile technology and communication and branding strategies.

Sebastian Perretta

Sebastian Perretta is an Economist from the UBA and throughout his career he has worked in the business sector of the veterinary industry.

Since 2002 he has gone through different areas of the company adding experience in Accounting, Finance, Management Control, Innovation, Marketing, Marketing and Communications, which has given a very broad and strategic vision of the global veterinary industry.

In 2015, he was appointed Director of Business Development and Strategy with the objective of global diversification of the company by geography and by species.

Sebastian Perretta

Sebastian Perretta is an Economist from the UBA and throughout his career he has worked in the business sector of the veterinary industry.

Since 2002 he has gone through different areas of the company adding experience in Accounting, Finance, Management Control, Innovation, Marketing, Marketing and Communications, which has given a very broad and strategic vision of the global veterinary industry.

In 2015, he was appointed Director of Business Development and Strategy with the objective of global diversification of the company by geography and by species.

Biogenesis Bagó is a company of Argentine capitals with which its contributions and that of its different teams have contributed for the company to be the first regional company in turnover in the segment of ruminants in Latin America.

Summing up his career, in the last five years he has accompanied the globalization stage of technologies, after having achieved consolidation in Latin America.

The business vision of the company always focused on strategically supporting the productive sectors, specifically the livestock and food production sector, with the scientific sector in betting on innovation as a way to approach business and the quality of products and services as a differential value.

During his tenure, the company was awarded important prizes such as Animal Pharm as the Best Latin American Company of the Veterinary Sector in 2014 and 2016, the "ICBC Foreign Trade 2016" Award that recognizes innovation, job creation and the ability of international companies to act , among many other distinctions of entities linked to its activity.

Roberto Cohen

General Manager, Head of M&A, Latin America

Henry Schein

Professional with unique, combined expertise in M&A transactions, business integration and operations. Deep knowledge in how to identify, oversee and run investments by US publicly traded companies in Latin America.

11 years of experience in cross-border M&A transactions, involved in every stage of the deal making process: from assessing strategic fit, determining valuation, coordinating due diligence, seeking Board approval in a Fortune-300 company environment, negotiating definitive agreements and, planning & executing post-close business integration.

Roberto Cohen

General Manager, Head of M&A, Latin America

Henry Schein

Professional with unique, combined expertise in M&A transactions, business integration and operations. Deep knowledge in how to identify, oversee and run investments by US publicly traded companies in Latin America.

11 years of experience in cross-border M&A transactions, involved in every stage of the deal making process: from assessing strategic fit, determining valuation, coordinating due diligence, seeking Board approval in a Fortune-300 company environment, negotiating definitive agreements and, planning & executing post-close business integration.

Operational experience in integrating newly acquired businesses and in transitioning them from a family-owned environment into a subsidiary of a larger organization, ensuring the continuation of an entrepreneurial environment but implementing the appropriate levels of compliance at the same time.

Led Henry Schein's entry and expansion in the Brazilian Dental market by closing 2 M&A transactions and led Henry Schein's entry into the Brazilian Animal Health market by closing 1 M&A transaction

Conference Packages

Sending Your Team? Group Discounts Available!

Applicable for Primary Market, Service Provider and Industry Rates Only. Not available for Academic or ‘Start-Up’ rates

Book a Team of 3+ - Save an Additional 10% OffBook a Team of 5+ - Save an Additional 15% Off

If you would like to register a team of 3 or more, please email [email protected] for your discount coupon code before registering. PLEASE NOTE: Discounts cannot be combined with Early Bird Pricing or any other discount or offer.If you have any questions about your registration, please call us on +44 (0)20 3696 2920

Socio principal

Boehringer Ingelheim

Boehringer Ingelheim is one of the world’s 20 leading pharmaceutical companies. Headquartered in Ingelheim, Germany, Boehringer Ingelheim operates presently with a total of some 50,000 employees worldwide. The focus of the family-owned company, founded in 1885, is on researching, developing, manufacturing and marketing new medications of high therapeutic value for human and veterinary medicine. In 2015, Boehringer Ingelheim achieved net sales of about 14.8 billion euros. R&D expenditure corresponds to 20.3 per cent of net sales.

Socio Asociado

Zoetis

Zoetis is the leading animal health company, dedicated to supporting its customers and their businesses. Building on more than 60 years of experience in animal health, Zoetis discovers, develops, manufactures and markets veterinary vaccines and medicines, complemented by diagnostic products, genetic tests, biodevices and a range of services. Zoetis serves veterinarians, livestock producers and people who raise and care for farm and companion animals with sales of its products in more than 100 countries. In 2016, the company generated annual revenue of $4.9 billion with approximately 9,000 employees.

Socios del evento

Argenta

Argenta Limited, founded in 2006, is the world’s only combined contract research organization (CRO) and contract manufacturing organization (CMO) specializing in animal health. With accredited operations and facilities across New Zealand, the United States and Scotland, Argenta is fully equipped to offer a full range of products and services - from access to innovative intellectual property, formulations research and development (R&D), analytical methods development, clinical trial management through to pilot- technical transfer and commercial-scale manufacturing - to the global animal health industry. Argenta’s 400+ global team develops and exports products and services to over 40 countries.

A privately-owned company headquartered in Auckland, New Zealand, Argenta brings innovation, R&D and manufacturing expertise together in one global company. This makes it ideally placed to accommodate unique product requirements no matter the scale or complexity. Argenta’s facilities in New Zealand, the United States (Iowa, Kansas and New Jersey) and Europe (Scotland) enable the achievement of significant efficiencies in product development and technology transfer, and to provide market intelligence and in-depth knowledge of market preferences in different countries as required.

Argenta is honoured to work with a vast range of clients globally - from small and medium-sized enterprises (SMEs) to some of the largest industry players. Argenta has the R&D capabilities and manufacturing scale to service the requirements of the largest multinationals, while, at the other end of the spectrum, Argenta works with startups and small companies with great ideas to help them find solutions and bring their ideas to fruition.

Biogénesis Bagó

Biogénesis Bagó is a biotechnology company with regional and international scope and more than 80 years of experience specialized in the development, production and trade of products for the sanity and breeding of animals. Through world reference scientific innovation and the certified quality of its processes and products (GMP,ISO 9001 and 14001), Biogénesis Bagó contributes the research of veterinary solutions for a higher productive efficiency. It is the only company in the field which has the products approved to be used against the Foot and Mouth Disease (FMD) in the United States of America and Canada. Their portfolio of products includes vaccines against the FMD, a world-class product with quality and technology highly recognized that protects one every three bovines of the region and helps the monitoring of the disease in most of the countries of the area where the vaccination is carried out; biological products; inter anti parasitic drugs composed by different drugs which allow the strategic monitoring and that avoid resistance; antibacterial drugs; vitamins and minerals; and reproductive. Biogénesis Bagó technical after-sales service is a key element for the correct use of technology since it is aimed to produce more effectively with the correct handling of the resources.

Elanco

Elanco provides comprehensive products and knowledge services to improve animal health and food-animal production in more than 70 countries around the world. We value innovation, both in scientific research and daily operations, and strive to cultivate a collaborative work environment for more than 6,500 employees worldwide. Together with our customers, we are committed to raising awareness about global food security, and celebrating and supporting the human-animal bond. We understand the powerful role healthy animals play in making lives better. We support the physical, emotional and social well-being of people thru a balanced diet rich in protein and the companionship of a pet. And, we preserve the health of the planet by helping farmers raise animals more efficiently. Since our start at Eli Lilly and Company in 1954, Elanco has been working to empower our customers—from veterinarians to food producers to all those concerned with animal health—to address these global challenges, and advance a vision of food and companionship enriching life. Visit us at Elanco.com and EnoughMovement.com.

ZENOAQ

ZENOAQ aims to create a shared and everlasting future for humans and animals. Amidst efforts to improve drug development, veterinary therapy and biotechnology, ZENOAQ strives to enhance the value of animals. The core activities in ZENOAQ are deeply connected with our customers, which in turn, affects their animals in many different ways. These connections form a network that is not just limited to Japan, but is something that will also reach across international borders, creating mutual benefit for both humans and animals in the future.

Socios publicitarios

Animal Pharm

The only source of animal health and animal nutrition news and analysis you’ll ever need.

Animal Pharm gathers intelligence from across the animal health and animal nutrition industries. It keeps you abreast of critical developments, emerging trends, and changes to the business, regulatory and competitive environment.

We have been providing animal health professionals worldwide with news, analysis and insight for over 30 years, and cover the food producing animal and companion animal sectors. With extensive information on animal health products including antiparasitics, vaccines, pharmaceuticals, feed, feed additives and equipment.

Features include:

Analysis of business and company news

Reporting on key players in the industry

Market developments and trends

Analysis of the latest global regulatory changes

News on product research and development

Expert opinion and analysis

CLAMEVET

Argentine Veterinary Laboratories Chamber (CLAMEVET) was founded in 2005 with the objectives of promoting, prestige and protect the veterinary industry and all the activities related to the production of veterinary medicinal products of national manufacture.

Nowadays, CLAMEVET brings together more than 50 veterinary laboratories of national capitals that are highly trained to guarantee the supply of veterinary products either to our market and to the rest of the world.

c. Attends every year CAMEVET’s meetings (Committee of the Americas on Veterinary Drugs), a regional project which main purpose is to facilitate the harmonization of standards for the registration of veterinary products throughout the American continent.

d. It has representation in the industrial branch of CAME (Argentine Confederation of the Medium Company)

VETsmart

Founded in 2012, VETsmart develops websites and applications for the veterinary medicine sector, for both small and large animals.

Become a Sponsor

Kisaco Research provides the much needed platform on which industry executives can network, connect and learn from each other as well as meet potential industry partners.

Far from the typical ‘meet-and-greet’ exhibition experience, you – as a sponsor or exhibitor – will be positioned as a partner of the event with a focus on the benefits of your product and brand, rather than just a name on an exhibition list.

With our extensive marketing experience and strategy, your partnership with Kisaco Research will grant you a sponsorship package that is an extension and enhancement of your current marketing and branding efforts. We value your ROI and will work with you directly on your specific goals and targets – that’s why we take special care in finding the most relevant end-users to attend, so that your financial and resource investment is smartly allocated.

About Kisaco Research

Meet industry peers that will help build a career-changing network for life.

Learn from the mistakes of your peers as much as their successes—ambitious industry stalwarts who are happy to share not just what has made them successful so far but also their plans for future proofing their companies.

Note down the inspired insight that will form the foundation for future strategies and roadmaps, both at our events and through our online communities.

Invest both in your company growth and your own personal development by signing up to one of our events and get started.

We'd love to hear from you.

Contact us at +44 (0)20 3696 2920 and email [email protected], or let us know what subject area you're interested in below.